NCT04365972View on ClinicalTrials.gov

Attention Bias Modification for Reducing Health Anxiety During the Coronavirus Pandemic

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 23, 2020

Primary Completion Date

April 30, 2020

Study Completion Date

April 30, 2020

Conditions
Anxiety
Interventions
BEHAVIORAL

Attention Bias Modification (ABM)

A home-delivered version of ABM will be administered in this open trial. ABM will be comprised of 5 sessions with a variation of the dot-probe task in which the target probe always replaces the neutral stimuli to induce diversion of attention away from threat. This condition was found effective in reducing anxiety symptoms.

Trial Locations (1)

6997801

Tel Aviv University, Tel Aviv

All Listed Sponsors
lead

Tel Aviv University

OTHER

NCT04365972 - Attention Bias Modification for Reducing Health Anxiety During the Coronavirus Pandemic | Biotech Hunter | Biotech Hunter